IL1B and cancer: A particular subtype of cancer-associated fibroblasts (CAFs) characterized by elevated IL-1 signaling, termed IL1R1+, has been identified in CRC, which facilitates tumor growth and immune suppression, underscoring the profound influence of IL-1 pathways on the TME by modulating tumor proliferation and immune response mechanisms (59).